Baolingbao Biology Co.,Ltd. (SHE:002286)
9.09
+0.11 (1.22%)
Jun 23, 2026, 3:04 PM CST
Baolingbao Biology Market Cap
Baolingbao Biology has a market cap or net worth of 3.42 billion as of June 22, 2026. Its market cap has decreased by -17.55% in one year.
Market Cap
3.42B
Enterprise Value
3.36B
Revenue
2.81B
Ranking
n/a
PE Ratio
21.76
Stock Price
9.09
Market Cap Chart
Since August 28, 2009, Baolingbao Biology's market cap has increased from 1.81B to 3.42B, an increase of 89.17%. That is a compound annual growth rate of 3.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 3.42B | 0.45% |
| Dec 31, 2025 | 3.40B | 24.68% |
| Dec 31, 2024 | 2.73B | -9.36% |
| Dec 29, 2023 | 3.01B | -10.92% |
| Dec 30, 2022 | 3.38B | -32.78% |
| Dec 31, 2021 | 5.03B | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Bohui Innovation Biotechnology Group | 3.64B |
| Kexing Biopharm | 3.59B |
| Shanghai Shen Lian Biomedical | 3.52B |
| Pulike Biological Engineering | 3.50B |
| Hefei Lifeon Pharmaceutical | 3.46B |
| Hinova Pharmaceuticals | 3.43B |
| Shanghai Obio Technology (Group) Corp. | 3.40B |
| Boji Medical Technology | 3.31B |